Why Sabra Health Care REIT (SBRA) Is Up 6.0% After 2025 Earnings And 2026 Dividend Guidance

Simply Wall St

Mon, February 16, 2026 at 6:08 AM GMT+9 3 min read

In this article:

SBRA

+1.10%

In February 2026, Sabra Health Care REIT, Inc. reported Q4 2025 results showing quarterly revenue of US$211.9 million and net income of US$27.23 million, alongside full-year 2025 net income of US$155.61 million and diluted EPS of US$0.64 from continuing operations.

The company paired these results with 2026 guidance targeting diluted EPS of US$0.60–US$0.64 and reaffirmed a quarterly dividend of US$0.30 per share, underscoring its focus on growing managed senior housing while keeping dividend coverage supported by normalized AFFO.

Next, we’ll examine how Sabra’s double-digit NOI growth in managed senior housing and 2026 earnings guidance influence its existing investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Sabra Health Care REIT Investment Narrative Recap

To own Sabra, you need to believe in its shift toward managed senior housing and the long term need for healthcare real estate, while accepting near term execution and reimbursement risks. The latest results and 2026 guidance, including modest EPS expectations, do not materially change the key short term catalyst, which is sustained NOI growth and occupancy gains in the senior housing operating portfolio, or the main risk around portfolio execution and capital allocation.

The reaffirmed US$0.30 quarterly dividend and management’s emphasis that it is supported by normalized AFFO are especially relevant here, because they tie Sabra’s dividend story directly to the same managed senior housing growth that underpins its 2026 earnings guidance. For investors watching how this growth balances against a relatively high payout and ongoing reinvestment needs, the dividend decision sits at the center of Sabra’s current risk reward trade off.

But investors should also be aware that if Sabra’s high payout ratio meets weaker operating performance or tenant stress, it could…

Read the full narrative on Sabra Health Care REIT (it’s free!)

Sabra Health Care REIT’s narrative projects $952.0 million revenue and $224.6 million earnings by 2028.

Uncover how Sabra Health Care REIT’s forecasts yield a $20.82 fair value, a 3% upside to its current price.

Exploring Other Perspectives

SBRA 1-Year Stock Price Chart

Three fair value estimates from the Simply Wall St Community range from US$11.59 to about US$49.75, showing very different views on Sabra’s upside. Against this wide spread, the company’s reliance on a heavy senior housing acquisition pipeline as a growth catalyst raises important questions about how more expansion could affect asset quality, margins and long term performance.

Story Continues  

Explore 3 other fair value estimates on Sabra Health Care REIT - why the stock might be worth 43% less than the current price!

Build Your Own Sabra Health Care REIT Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

A great starting point for your Sabra Health Care REIT research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Our free Sabra Health Care REIT research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Sabra Health Care REIT's overall financial health at a glance.

Interested In Other Possibilities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Invest in the nuclear renaissance through our list of 85 elite nuclear energy infrastructure plays powering the global AI revolution.

Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include SBRA.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info